Overexpression Of hsa-miR-664a-3p Is Associated With Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Via Targeting FHL1

被引:26
作者
Zhong, Shan [1 ,2 ]
Chen, Chengshui [3 ]
Liu, Naijia [2 ]
Yang, Li [3 ]
Hu, Zhangli [2 ]
Duan, Pengfei [1 ]
Shuai, Diquan [2 ]
Zhang, Qingying [1 ]
Wang, Yun [2 ]
机构
[1] Shantou Univ, Dept Prevent Med, Med Coll, Shantou 515041, Guangdong, Peoples R China
[2] Shenzhen Univ, Coll Life Sci & Oceanog, Ctr Res & Technol Precis Med, Xili Campus,1066,Xueyuan Ave, Shenzhen 518055, Guangdong, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp, Wenzhou 325000, Zhejiang, Peoples R China
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019年 / 14卷
关键词
COPD; miRNA; mRNA; co-expression networks; biomarker; EPITHELIAL-CELL APOPTOSIS; POTENTIAL BIOMARKER; EXPRESSION; INFLAMMATION; MICRORNA; GENE; COPD;
D O I
10.2147/COPD.S224763
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Chronic obstructive pulmonary disease (COPD) is recognized as a chronic lung disease with incomplete reversible airflow limitation, but its pathophysiology was still not clear. This study aimed at investigating regulatory roles of special miRNA-mRNA axis in COPD development. Methods: Differentially expressed miRNAs and downstream mRNAs were screened from the Gene Expression Omnibus (GEO) dataset by using the LIMMA package in R software. Weighted Gene Co-expression Network Analysis (WGCNA) was used to construct a co-expression network for COPD. The correlation of dysregulated miRNA(s) and COPD was analyzed, and miRNAs with significant differences were validated in peripheral blood mononuclear cells (PBMCs) from COPD patients by real-time PCR. Regulatory roles of candidate miRNAs and targeted mRNAs were investigated in vitro study. Results: Thirteen modules of co-expressed miRNAs and mRNAs were constructed from a selected cohort with WGCNA. Turquoise module with 12 differentially expressed miRNAs and 120 mRNAs was significantly correlated with COPD. The expression of hsa-miR-664a-3p, an upregulated miRNA in the module, was increased both in lung tissue and PBMCs from COPD patients, whereas that targeted four and a half LIM domains 1 (FHL1) gene was decreased and positively correlated with forced expiratory volume in 1 sec (FEV1)/forced vital capacity (FVC%) (r = 0.59, p < 0.01). In vitro, luciferase activity assay revealed FHL1 as a target of hsa-miR-664a-3p and it could be directly downregulated by overexpression of hsa-miR-664a-3p. Furthermore, cigarette smoke extract could increase hsa-miR-664a-3p level and decrease FHL1 level in Beas-2B cells. Conclusion: The present study validated significant upregulation of hsa-miR-664a-3p in COPD patients, and its target gene FHL1 was downregulated and positively correlated with FEV1/FVC%; both hsa-miR-664a-3p and FHL1 could be regulated by cigarette smoke extract.Results of bioinformatic analyses and expanded validation suggest that the axis from hsa-miR-664a-3p to FHL1 might play a key role in cigarette smoke-induced COPD, and the exact mechanism should be confirmed in further studies.
引用
收藏
页码:2319 / 2329
页数:11
相关论文
共 41 条
  • [1] FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect
    Asada, K.
    Ando, T.
    Niwa, T.
    Nanjo, S.
    Watanabe, N.
    Okochi-Takada, E.
    Yoshida, T.
    Miyamoto, K.
    Enomoto, S.
    Ichinose, M.
    Tsukamoto, T.
    Ito, S.
    Tatematsu, M.
    Sugiyama, T.
    Ushijima, T.
    [J]. ONCOGENE, 2013, 32 (17) : 2140 - 2149
  • [2] Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7
    Bao, Yongzheng
    Chen, Bin
    Wu, Qiang
    Hu, Konghe
    Xi, Xinhua
    Zhu, Wengang
    Zhong, Xueren
    Chen, Jianting
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 17 (01) : 51 - 58
  • [3] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [4] Serum microRNAs as non-invasive biomarkers for cancer
    Brase, Jan C.
    Wuttig, Daniela
    Kuner, Ruprecht
    Sueltmann, Holger
    [J]. MOLECULAR CANCER, 2010, 9
  • [5] X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma
    Cao, Wei
    Liu, Jiannan
    Xia, Ronghui
    Lin, Lu
    Wang, Xu
    Xiao, Meng
    Zhang, Chenping
    Li, Jiang
    Ji, Tong
    Chen, Wantao
    [J]. ONCOTARGET, 2016, 7 (12) : 14537 - 14550
  • [6] Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
    Comer, David M.
    Kidney, Joseph C.
    Ennis, Madeleine
    Elborn, J. Stuart
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1058 - 1067
  • [7] MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease
    Conickx, Griet
    Mestdagh, Pieter
    Cobos, Francisco Avila
    Verhamme, Fien M.
    Maes, Tania
    Vanaudenaerde, Bart M.
    Seys, Leen J. M.
    Lahousse, Lies
    Kim, Richard Y.
    Hsu, Alan C.
    Wark, Peter A.
    Hansbro, Philip M.
    Joos, Guy F.
    Vandesompele, Jo
    Bracke, Ken R.
    Brusselle, Guy G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (01) : 43 - 56
  • [8] Chronic obstructive pulmonary disease
    Decramer, Marc
    Janssens, Wim
    Miravitlles, Marc
    [J]. LANCET, 2012, 379 (9823) : 1341 - 1351
  • [9] Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β-like signaling pathway
    Ding, Lihua
    Wang, Zhaoyun
    Yan, Jinghua
    Yang, Xiao
    Liu, Aijun
    Qiu, Weiyi
    Zhu, Jianhua
    Han, Juqiang
    Zhang, Hao
    Lin, Jing
    Cheng, Long
    Qin, Xi
    Niu, Chang
    Yuan, Bin
    Wang, Xiaohui
    Zhu, Cui
    Zhou, Yan
    Li, Jiezhi
    Song, Haifeng
    Huang, Cuifen
    Ye, Qinong
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (02) : 349 - 361
  • [10] MicroRNAs in lung diseases: Recent findings and their pathophysiological implications
    Ebrahimi, Ammar
    Sadroddiny, Esmaeil
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 34 : 55 - 63